Transaction · 0001213900-26-060632

Zhai Yifan

Zhai Yifan, CMO, reported a transaction classified as exercise at ASCENTAGE PHARMA GROUP INTERNATIONAL involving 95575.000000 shares for an estimated $0.00. Reported holdings after the transaction were 0.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

exerciseSEC transaction code MCMO
AAPGASCENTAGE PHARMA GROUP INTERNATIONAL
Trade date
May 21, 2026
Filing date
May 22, 2026
View on SEC Insider profile
Disclosed value$0Shares × reported price
Shares traded95.5k$0.00 per share
Holdings after0Indirect · By Spouse
% of reported position tradedUnavailableThis security and ownership context
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

AAPG price since this filing

Daily closing prices, with the filing date and available return windows
AAPG · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +22.1%1w ago -4.0%1d ago -5.9%
Returns since7d -4.8%30d -18.5%90d -17.6%180d1y

Transaction facts

Stored Form 4 columns with their raw values

Derivative
Type
exercise
Code M
Identifier
0001213900-26-060632
Restricted stock units
Transaction date
May 21, 2026
Filed May 22, 2026, 08:44 PM · 1d delay
Shares
95,575 sh
$0.00 per share
Estimated value
$0
Computed from shares × price
Holdings after
0 sh
Indirect · By Spouse

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Derivative Transaction
Filing-only score

-12 points

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

How this score is calculated
  • timely_filing+4 points

    reporting_delay_days = 1

    Filing reported within two business days of the transaction.
  • derivative_transaction-16 points

    is_derivative = true

    Derivative exercise rows are less discretionary than open-market purchases.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Chief Medical Officer

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1F2F3(3 footnotes)

    Shares held by Dajun Yang Dynasty Trust, of which the Reporting Person's spouse is the investment advisor. The Reporting Person disclaims beneficial ownership over such securities except to the extent…

  2. F4

    Each restricted stock unit (the "RSUs") represents a contingent right to receive one Ordinary Share of the Issuer upon vesting. The RSUs vest in four equal increments on November 26, 2026, 2027, 2028…

  3. F5

    The RSUs vest in four equal increments on May 21, 2027, 2028, 2029 and 2030 and have no expiration date.

  4. F6

    The exercise price of the options is in HKD and the exercise price included in the table represents conversion to USD based on the exchange rate as of the date of grant. The options vest in four equal…

  5. F7

    The exercise price of the options is in HKD and the exercise price included in the table represents conversion to USD based on the exchange rate as of the date of grant. The options vest in four equal…

  6. F8

    The RSUs vested on 05/21/2026 and had no expiration date.

  7. F9

    Represents the vesting in full on 5/21/2026 of the RSUs granted to the Reporting Person on 05/20/2026.

  8. F10

    Represents the vesting in full on 5/21/2026 of the RSUs granted to the Reporting Person's spouse on 05/20/2026.

Original filing · 0001213900-26-060632
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

AAPG